With the emergence of COVID-19, Cytotheryx remains committed to developing a consistent, high-quality source of human hepatocytes as we work together through this unprecedented and ever-changing time in our country. Learn More
News & Events

COVID-19 Statement

Posted on: April 2, 2020   |   Category: News

With the emergence of COVID-19, Cytotheryx remains committed to developing a consistent, high-quality source of human hepatocytes as we work together through this unprecedented and ever-changing time in our country. Therefore, we want to address a few questions or concerns that might arise:

  • We remain committed to delivering value to our investors and partners, especially during this time when it is important to be good corporate citizens, protect our team and continue our vital work.
  • We are taking precautions in order to halt the spread of the virus in our community. Our offices will be closed for non-essential team members starting March 18th through April 10th, and employees, if possible, will be working from home during this time.
  • Essential staff will continue their work at our facilities while taking additional precautions for their own safety and we will be monitoring the situation closely as data continues to become available.
  • If you have any questions about these guidelines, please email contact@cytotheryx.com.

We remain dedicated to our goals and will transparently share updates during this time of concern and beyond. Please check back for updates to this information as the situation changes.